During the past decade, Berman Center for Outcomes and Clinical Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Berman Center for Outcomes and Clinical Research" #1 sponsor was "Axio Research. LLC" with 1 trials, followed by "Cytokinetics" with 1 trials sponsored, "Mt. Sinai Medical Center, Miami" with 1 trials sponsored, "Targacept Inc." with 1 trials sponsored and "University of British Columbia" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Berman Center for Outcomes and Clinical Research" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Berman Center for Outcomes and Clinical Research" are "Cerebrovascular Accident" (2 trials), "Age-Related Memory Disorders" (1 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Atherosclerosis" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Berman Center for Outcomes and Clinical Research" in a lesser frequency.

Most popular intervention types in "Berman Center for Outcomes and Clinical Research" are "Drug" (6 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bupropion: Wellbutrin XL®" (1 trials), "CK-2017357" (1 trials), "EDTA" (1 trials), "EDTA Placebo" (1 trials) and "Extended release niacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Berman Center for Outcomes and Clinical Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Berman Center for Outcomes and Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Berman Center for Outcomes and Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Berman Center for Outcomes and Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".